Our analysis using two distinct data sources indicates that B3GNT5 expression is inversely associated with CD8+ T lymphocytes, CD4+ T lymphocytes, and natural killer cells, which could help shed light on the connection between B3GNT5 and diverse tumor types. This evidence concerns the gene CD8A and neoplasm.